Anti-Sclerostin antibody
5
(2 Reviews)
|
(11 Publications)
Rabbit Polyclonal Sclerostin antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 11 publications.
View Alternative Names
UNQ2976/PRO7455/PRO7476, SOST, Sclerostin
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Sclerostin antibody (AB85799)
ab85799 staining Sclerostin in HepG2 cells. The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% PBS-Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab85799 at 1µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue). Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.
- WB
Unknown
Western blot - Anti-Sclerostin antibody (AB85799)
All lanes:
Western blot - Anti-Sclerostin antibody (ab85799) at 1 µg/mL
All lanes:
Human bone tumor tissue lysate - total protein (<a href='/en-us/products/unavailable/human-bone-tumor-tissue-lysate-total-protein-ab29359'>ab29359</a>) at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 24 kDa
Observed band size: 150 kDa,28 kDa,55 kDa
true
Exposure time: 20min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Sclerostin inhibits osteoblastic activity and formation by interfering with bone morphogenetic proteins. It doesn’t form part of a large protein complex but interacts directly with cell surface receptors. Its expression decreases in response to mechanical loading on bones which is an important part of regulating bone density and remodeling. By controlling osteoblast function sclerostin contributes to skeletal homeostasis an essential process for maintaining bone strength and integrity.
Pathways
Several mechanisms regulate sclerostin activity. In the canonical Wnt/β-catenin signaling pathway it serves as an important checkpoint that ensures controlled bone formation. Sclerostin acts by preventing the activation of LRP5/6 receptors pivotal components in this pathway. Additionally it shares a regulatory network with dickkopf-1 (DKK1) another Wnt inhibitor both of which have an influence on bone metabolism and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8282 PubMed40987787
2025
Applications
Unspecified application
Species
Unspecified reactive species
Progress in orthodontics 25:45 PubMed39581932
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular diabetology 22:301 PubMed37919715
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 11:1250070 PubMed37822871
2023
Applications
Unspecified application
Species
Unspecified reactive species
JBMR plus 7:e10792 PubMed37701151
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 14:1167734 PubMed37223031
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 18:162 PubMed36864451
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biology 11: PubMed36552348
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:4241 PubMed35869074
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:197 PubMed33488806
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com